AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Southey, MC Young, MA Whitty, J Mifsud, S Keilar, M Mead, L Trute, L Aittomaki, K McLachlan, SA Debinski, H Venter, DJ Armes, JE
Citation: Mc. Southey et al., Molecular pathologic analysis enhances the diagnosis and management of Muir-Torre syndrome and gives insight into its underlying molecular pathogenesis, AM J SURG P, 25(7), 2001, pp. 936-941

Authors: Brown, GJE St John, DJB Macrae, FA Aittomaki, K
Citation: Gje. Brown et al., Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: Implications for gynecologic surveillance, GYNECOL ONC, 80(3), 2001, pp. 346-349

Authors: Gaff, C Aittomaki, K Williamson, R
Citation: C. Gaff et al., Oncology nurse training in cancer genetics, J MED GENET, 38(10), 2001, pp. 691-695

Authors: Aittomaki, K Eroila, H Kajanoja, P
Citation: K. Aittomaki et al., A population-based study of the incidence of mullerian aplasia in Finland, FERT STERIL, 76(3), 2001, pp. 624-625

Authors: Vahteristo, P Tamminen, A Karvinen, P Eerola, H Eklund, C Aaltonen, LA Blomqvist, C Aittomaki, K Nevanlinna, H
Citation: P. Vahteristo et al., p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: Further evidence of CHK2 in inherited cancer predisposition, CANCER RES, 61(15), 2001, pp. 5718-5722

Authors: Kiuru, M Launonen, V Hietala, M Aittomaki, K Vierimaa, O Salovaara, R Arola, J Pukkala, E Sistonen, P Herva, R Aaltonen, LA
Citation: M. Kiuru et al., Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology, AM J PATH, 159(3), 2001, pp. 825-829

Authors: Shelling, AN Burton, KA Chand, AL van Ee, CC France, JT Farquhar, CM Milsom, SR Love, DR Gersak, K Aittomaki, K Winship, IM
Citation: An. Shelling et al., Inhibin: a candidate gene for premature ovarian failure, HUM REPR, 15(12), 2000, pp. 2644-2649

Authors: Meiser, B Butow, P Barratt, A Friedlander, M Kirk, J Gaff, C Haan, E Aittomaki, K Tucker, K
Citation: B. Meiser et al., Breast cancer screening uptake in women at increased risk of developing hereditary breast cancer, BREAST CANC, 59(2), 2000, pp. 101-111

Authors: Aittomaki, K Huhtaniemi, IT
Citation: K. Aittomaki et It. Huhtaniemi, FSH resistance, CONT ENDOC, 14, 1999, pp. 197-207

Authors: Tapanainen, JS Vaskivuo, T Aittomaki, K Huhtaniemi, IT
Citation: Js. Tapanainen et al., Inactivating FSH receptor mutations and gonadal dysfunction, MOL C ENDOC, 145(1-2), 1998, pp. 129-135

Authors: Jiang, N Aittomaki, K Nilsson, C Pakarinen, P Iitia, A Torresani, T Simonsen, K Goh, V Pettersson, K de la Chapelle, A Huhtaniemi, I
Citation: N. Jiang et al., The frequency of an inactivating point mutation (C-566 -> T) of the human follicle-stimulating hormone receptor gene in four populations using allele-specific hybridization and time-resolved fluorometry, J CLIN END, 83(12), 1998, pp. 4338-4343
Risultati: 1-11 |